Finance

Lists
Why is EWL up 2,52%?
Dive Deeper
EWL:ETR
Edwards Lifesciences Corp
76,38 €
+2,52%
(+1,88) 1D
12-окт., 13:17:52 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EWL...
Open
76,78 €
High
76,78 €
Low
76,38 €
Mkt. cap
49,12 млд
Avg. vol.
61,00
Volume
2,00
52-wk high
84,00 €
52-wk low
62,00 €
No. of employees
16 миң
Open
76,78 €
High
76,78 €
Low
76,38 €
Mkt. cap
49,12 млд
Avg. vol.
61,00
Volume
2,00
52-wk high
84,00 €
52-wk low
62,00 €
No. of employees
16 миң
News stories
From web sources and news partners
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 миң
Founded1958
HeadquartersИрвайн, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,55 млд
1,57 млд
1,65 млд
1,74 млд
Cost of goods sold
345,20 млн
343,00 млн
362,60 млн
392,40 млн
Cost of revenue
345,20 млн
343,00 млн
362,60 млн
392,40 млн
Research and development expenses
280,70 млн
267,70 млн
263,30 млн
278,90 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
514,60 млн
601,20 млн
522,20 млн
561,20 млн
Operating expense
782,80 млн
854,60 млн
771,30 млн
829,10 млн
Total operating expenses
1,13 млд
1,20 млд
1,13 млд
1,22 млд
Operating income
425,10 млн
372,00 млн
514,70 млн
519,50 млн
Other non operating income
1,10 млн
2,30 млн
69,90 млн
-25,00 млн
EBT including unusual items
348,40 млн
90,40 млн
459,00 млн
519,80 млн
EBT excluding unusual items
444,50 млн
464,00 млн
603,60 млн
511,10 млн
Income tax expense
56,10 млн
26,20 млн
78,30 млн
278,40 млн
Effective tax rate
16,10%
28,98%
17,06%
53,56%
Other operating expenses
-12,50 млн
-14,30 млн
-14,20 млн
-11,00 млн
Net income
291,10 млн
91,20 млн
380,70 млн
241,90 млн
Net profit margin
18,74%
5,81%
23,09%
13,89%
Earnings per share
0,67
0,58
0,78
0,78
Interest and investment income
16,70 млн
114,20 млн
17,40 млн
15,00 млн
Interest expense
-
-20,40 млн
-
-
Net interest expenses
16,70 млн
93,80 млн
17,40 млн
15,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
464,30 млн
414,70 млн
555,60 млн
562,20 млн
Gain or loss from assets sale
-
-33,90 млн
-
-
AI content may include mistakes. Learn more
Google колдонмолору